Cleopatra Kollias-Perez

Cleopatra Kollias-Perez has extensive experience in pharmaceuticals and pharmacovigilance, with past roles at companies such as Vir Biotechnology, The Janssen Pharmaceutical Companies of Johnson & Johnson, Pfizer Pharmaceuticals, and Abbott. Currently serving as Vice President of Global Pharmacovigilance & Risk Management at Vir Biotechnology, Cleopatra has held senior positions in safety evaluation and reporting throughout their career.